Tragen Basistherapeutika in der Therapie rheumatischer Erkrankungen zu Wundheilungsstörungen bei? Sollten sie perioperativ abgesetzt werden?

Schlüsselwörter

Basistherapeutika - DMARD - Methotrexat - Biologika - Immunsuppression

Key words

DMARDs - methotrexate - biologicals - immunosuppression

Literatur

• 1 Agnes M, Boerbooms T, Kerstens P JSM, van Loenhout J WA, Mulder J, van de Putte L BA. Infections during low-dose methotrexate treatment in Rheumatoid Arthritis.  Semin Arthritis Rheum. 1995;  24 411-421
• 2 Anstead G M. Steroids, retinoids, and wound healing.  Adv Wound Care. 1998;  11 277-285
• 3 Beck A, Salem K, Krischak G, Kinzl L, Bischoff M, Schmelz A. Nichtsteroidale Antirheumatika (NSAR) in der perioperativen Phase in Traumatologie und Orthopädie. Einfluss auf die Knochenheilung.  Oper Orthop Traumatol. 2005;  17 569-578
• 4 Bridges S L, Lopez-Mendez A, Han K H, Tracy I C, Alarcon G S. Should methotrexate be discontinued before elective orthopaedic surgery in patients with rheumatoid arthritis?.  J Rheumatol. 1991;  18 984-988
• 5 Carpenter M T, West S G, Vogelgesang S A, Casey Jones D E. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy.  Orthopedics. 1996;  19 207-210
• 6 Den Broeder A A, Schraven T, De Jong E, De Rooij D, van den Hoogen F. Infectious complications in elective surgery in RA patients in the anti-TNF era: a retrospective study.  Ann Rheum Dis. 2005;  64 (Suppl III) 60
• 7 Dixon W G, Lunt M, Watson K D, Hyrich K L. Anti-TNF therapy and the risk of serious post-operative infection: results from the BSR biologics register (BSRBR).  Ann Rheum Dis. 2007;  66 (Suppl II) 118
• 8 Doran M F, Crowson C S, Pond G R, O’Fallon M, Gabriel S E. Frequency of Infection in patients with rheumatoid arthritis compared with controls. A population based study.  Arthritis Rheum. 2002;  46 2287-2293
• 9 Doran M F, Crowson C S, Pond G R, O’Fallon W M, Gabriel S E. Predictors of infection in rheumatoid arthritis.  Arthritis Rheum. 2002;  46 2294-2300
• 10 Escalante A, Beardmore T D. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis.  J Rheumatol. 1995;  22 1844-1851
• 11 Fuerst M, Mohl H, Baumgartel K, Ruther W. Leflunomid increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopaedic.  Rheumatol Int. 2006;  26 1138-1142
• 12 Glück T, Kiefmann B, Grohmann M, Falk W, Straub R H, Schölmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy.  J Rheumatol. 2005;  32 1473-1480
• 13 Grennan D M, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery.  Ann Rheum Dis. 2001;  60 214-217
• 14 Haugeberg G, Strand A, Kvien T K, Kirwan J R. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial.  Arch Intern Med. 2005;  165 1293-1297
• 15 Jain A, Witbreuk M, Ball C, Nanchahal J. Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery.  J Hand Surg. 2002;  27 449-455
• 16 Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A. Infections in patients with rheumatoid arthritis treated with biologic agents.  Arthritis Rheum. 2005;  52 3403-3412
• 17 Matthews J LK, Martin L, Hu R. Post operative complications in rheumatoid arthritis patients on anti-TNF therapies undergoing orthopaedic procedures.  Ann Rheum Dis. 2006 ;  65 (Suppl II ) 331
• 18 Murata K, Yasuda T, Ito H, Yoshida M, Nakamura T. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery.  Mod Rheumatol. 2006;  16 14-19
• 19 Perhala R S, Wilke W S, Clough J D, Segal A M. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate.  Arthritis Rheum. 1991;  34 146-152
• 20 Pieringer H, Stuby U, Biesenbach G. patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment.  Semin Arthritis Rheum. 2007;  36 278-286
• 21 Rehart S, Petak N. Moderne rheumatische Basistherapie postoperativ. Patienten des rheumatischen Formenkreises unter Therapie mit Methotrexat, Leflunomid bzw. TNF-alfa Blockern perioperativ.  Akt Rheumatol. 2007;  32 74-77
• 22 Sany J, Anaya J M, Canovas F, Combe B, Jorgensen C, Saker S. et al . Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis.  J Rheumatol. 1993;  20 1129-1132
• 23 Shamberger R C, Devereux D F, Brennan M F. The effect of chemotherapeutic agents on wound healing.  Int Adv Surg Oncol. 1981;  4 15-58
• 24 Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis.  J Clin Rheumatol. 2003;  9 115-118
• 25 Wendling D, Balblanc J C, Brousse A, Lohse A, Lehuede G, Garbuio P, Toussirot E, Auge B, Jacques D. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.  Ann Rheum Dis. 2005;  64 1378-1379